SEITO Biologics raises over CHF 2.8M

SEITO develops regulatory T-cell therapies for autoimmune and inflammatory diseases.

3 June 2025

More news

1 Sept

ETH researchers use directional freezing to give whole-legume preparations a fibrous texture without extracting isolated proteins.

27 Nov 2025

Oncobit develops liquid biopsy tests and software for monitoring cancer.

13 Nov 2025

Virometix develops synthetic vaccines against infectious diseases.

6 Nov 2025

arcoris bio develops biomarker detection technology for digital pathology.